Home / Health / AI Becomes Radiologists' Second Eyes for Prostate Cancer
AI Becomes Radiologists' Second Eyes for Prostate Cancer
23 Oct
Summary
- AI software will assist doctors in identifying prostate cancer on MRI scans.
- Five specific AI tools will be trialled across the NHS for two years.
- AI aims to improve accuracy and speed of diagnosis, supporting but not replacing radiologists.
Artificial intelligence programs are being deployed across the NHS in England to assist radiologists in identifying prostate cancer on MRI scans, functioning as a 'second pair of eyes' for clinical staff. Five specific AI tools have been recommended and will undergo a two-year trial across the NHS to collect further evidence on their performance.
These AI systems are designed to support radiologists by pinpointing areas on prostate scans where cancer may be present. This initiative addresses the rising demand for prostate MRIs and the strain on already pressured radiology teams. Experts believe AI can enhance the accuracy and consistency of MRI interpretations.
The technology aims to support, not replace, radiologists, who will continue to review all scans and AI findings before patient care decisions are made. This development is seen as a significant step towards faster and more accurate diagnoses for men with prostate cancer, while also providing quicker all-clear results for those without the disease, thereby reducing patient anxiety.
